Clinical Trial Update: Visilizumab for Treatment of Perianal Fistulas in Crohn's Disease [Phase 2]

View source ↗

Summary

This is a completed Phase 2 clinical trial evaluating visilizumab for treatment of perianal fistulas in Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Visilizumab (visilizumab)

Snippet

Sponsor: Facet Biotech | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED